TY - JOUR
T1 - Mapping the binding domains of the αIIb subunit
T2 - A study performed on the activated form of the platelet integrin α IIbβ3
AU - Biris, Nikolaos
AU - Abatzis, Morfis
AU - Mitsios, John V.
AU - Sakarellos-Daitsiotis, Maria
AU - Sakarellos, Constantinos
AU - Tsoukatos, Demokritos
AU - Tselepis, Alexandros D.
AU - Michalis, Lambros
AU - Sideris, Dimitrios
AU - Konidou, Georgia
AU - Soteriadou, Ketty
AU - Tsikaris, Vassilios
PY - 2003/9/1
Y1 - 2003/9/1
N2 - αIIbβ3, a member of the integrin family of adhesive protein receptors, is the most abundant glycoprotein on platelet plasma-membranes and binds to adhesive proteins via the recognition of short amino acid sequences, for example the ubiquitous RGD motif. However, elucidation of the ligand-binding domains of the receptor remains controversial, mainly owing to the fact that integrins are conformationally labile during purification and storage. In this study, a detailed mapping of the extracellular region of the αIIb subunit is presented, using overlapping 20-peptides, in order to identify the binding sites of α IIb potentially involved in the platelet-aggregation event. Regions αIIb 313-332, αIIb 265-284 and α IIb 57-64 of αIIbβ3 were identified as putative fibrinogen-binding domains because the corresponding peptides inhibited platelet aggregation and antagonized fibrinogen association, possibly by interacting with this ligand. The latter is further supported by the finding that the above peptides did not interfere with the binding of PAC-1 to the activated form of αIIbβ3. Furthermore, αIIb313-332 was found to bind to fibrinogen in a solid-phase binding assay. It should be emphasized that all the experiments in this study were carried out on activated platelets and consequently on the activated form of this integrin receptor. We hypothesize that RAD and RAE adhesive motifs, encompassed in αIIb 313-332, 265-284 and 57-64, are capable of recognizing complementary domains of fibrinogen, thus inhibiting the binding of this ligand to platelets.
AB - αIIbβ3, a member of the integrin family of adhesive protein receptors, is the most abundant glycoprotein on platelet plasma-membranes and binds to adhesive proteins via the recognition of short amino acid sequences, for example the ubiquitous RGD motif. However, elucidation of the ligand-binding domains of the receptor remains controversial, mainly owing to the fact that integrins are conformationally labile during purification and storage. In this study, a detailed mapping of the extracellular region of the αIIb subunit is presented, using overlapping 20-peptides, in order to identify the binding sites of α IIb potentially involved in the platelet-aggregation event. Regions αIIb 313-332, αIIb 265-284 and α IIb 57-64 of αIIbβ3 were identified as putative fibrinogen-binding domains because the corresponding peptides inhibited platelet aggregation and antagonized fibrinogen association, possibly by interacting with this ligand. The latter is further supported by the finding that the above peptides did not interfere with the binding of PAC-1 to the activated form of αIIbβ3. Furthermore, αIIb313-332 was found to bind to fibrinogen in a solid-phase binding assay. It should be emphasized that all the experiments in this study were carried out on activated platelets and consequently on the activated form of this integrin receptor. We hypothesize that RAD and RAE adhesive motifs, encompassed in αIIb 313-332, 265-284 and 57-64, are capable of recognizing complementary domains of fibrinogen, thus inhibiting the binding of this ligand to platelets.
KW - Integrin inhibitors
KW - Platelet-aggregation inhibitors
KW - α mapping
KW - α-binding domains
KW - αβ receptor
UR - http://www.scopus.com/inward/record.url?scp=0141447378&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0141447378&partnerID=8YFLogxK
U2 - 10.1046/j.1432-1033.2003.03762.x
DO - 10.1046/j.1432-1033.2003.03762.x
M3 - Article
C2 - 12950259
AN - SCOPUS:0141447378
SN - 1742-464X
VL - 270
SP - 3760
EP - 3767
JO - FEBS Journal
JF - FEBS Journal
IS - 18
ER -